📰 Anthony Devlin Bloomberg News
Page 3 - Anthony Devlin Bloomberg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anthony Devlin Bloomberg. Real-time updates on events, politics, business and more.
April 8, 2021
AstraZeneca Worries Complicate Bid to Vaccinate the World Bloomberg 2 hrs ago James Paton, Tim Loh and Todd Gillespie (Bloomberg) -- Growing worries that AstraZeneca Plc’s Covid-19 vaccine causes rare blood clots could hinder immunization campaigns across the world, from London to Seoul. Reviews by U.K. and European Union regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are ...
February 22, 2021
Johnson opts for slow end to lockdown Emily Ashton and Alex Morales, Bloomberg Feb. 22, 2021 FacebookTwitterEmail A social-distancing floor marker sits in a classroom at All Saints Catholic College in Manchester, England, on Sept. 1, 2020.Bloomberg photo by Anthony Devlin British Prime Minister Boris Johnson declared the end of the pandemic is "in sight" for England as he set out his aim to ease lockdown rules in a series of stages over the next four months. Johnson detailed a four-step plan t...
February 10, 2021
Electronics goods face biggest tariff hikes in India’s Atmanirbhar push Premium Share Via Read Full Story India’s latest budget, tabled in Parliament on 1 February, came with a fresh set of tariff hikes. Coming after months of the ‘Atmanirbhar Bharat’ push, the hikes inevitably lent steam to India’s increasingly protectionist image. A sectoral analysis shows that the electronics goods sector, which depends heavily on China, continued to be among the biggest targets of India’s tariff...
February 10, 2021
Saudi Arabia’s sovereign wealth fund, the Public Investment Fund, is increasingly playing a bigger role in the economy and intends to invest around $40 billion each year in the local economy
February 10, 2021
I am now on Koo, Railway Minister Piyush Goyal pushes for Made-in-India app Premium 2 min read Koo won the Aatmanirbhar App Challenge organised by the Indian government Prime Minister Narendra Modi had, in one of his Mann Ki Baat monthly radio talks, encouraged Indians to use Koo Share Via Read Full Story Koo, Made-in-India app, is seen as an alternative to US microblogging site Twitter. Railway Minister Piyush Goyal also joined the desi app. Taking to Twitter, he said, "I am now on Koo." Railw...
February 8, 2021
Virginia Mayo/AP/Shutterstock Vaccines from Johnson & Johnson and Novavax report positive trial results A coronavirus vaccine developed by the US firm Novavax has been shown to be 89 per cent effective in preventing covid-19 in clinical trials. The trials included participants in the UK and South Africa, and found the vaccine to be 86 per cent effective against the UK variant of the virus, but only 60 per cent effective against the variant in South Africa. Novavax said it will immediately begin...
January 27, 2021
Lockdown exposes inequality in Hong Kong, deaths cross 1 lakh-mark in UK & other Covid news As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe. Angana Chakrabarti 27 January, 2021 1:29 pm IST Text Size: A+ New Delhi: The novel coronavirus pandemic continues to devastate countries across the world — the latest count being over 10 crore cases and more than 21 lakh deaths. Lo...
January 26, 2021
Europe threatens to restrict vaccine exports after AstraZeneca and Pfizer hit production problems CNN 1/26/2021 By Julia Horowitz, CNN Business © Anthony Devlin/Bloomberg/Getty Images Vials of the AstraZeneca Plc and the University of Oxford Covid-19 vaccine at the Royal Health & Wellbeing Centre in Oldham, U.K., on Thursday, Jan. 21, 2021. Boris Johnsons government is pinning its hopes on a mass vaccination program to reduce hospitalizations and ultimately deaths, and aims...
January 15, 2021
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic